Donald Trump
U.S. Supreme Court Rules Trump’s Tariffs Unlawful, Questions Remain
On Feb. 20, the United States Supreme Court ruled in the consolidated case Learning Resources, Inc. v. Trump that the International Emergency Economic Powers Act (IEEPA) does not grant the President of the United States the authority to impose tariffs. The ruling found almost all the major tariffs implemented by the current administration were unlawful, including wide-ranging, nation-scale ...
Administration Provides Tariff Relief for Certain Botanical Ingredients
As part of an executive order issued on Nov. 14, President Donald Trump revised and expanded the set of commodities in the Harmonized Tariff Schedule (HTS) that are exempt from reciprocal tariffs. These changes, which are reflected in updates to Annex II and Annex III partially target commodities that cannot be sourced within the United ...
AHPA Responds to Annex III Tariff Rules for Herbal Commodities
On Sept. 5, President Donald Trump passed a new executive order taking a range of actions regarding the tariff policies. The changes include the addition of Annex III, which contains commodities that may be exempt from the reciprocal tariffs. According to the American Herbal Products Association (AHPA), the herbal commodities in Annex III include those ...
NPA Analysis Shows Cost Savings From Annex II Tariff Exemptions
On July 2, the Natural Products Association (NPA) released a comprehensive economic analysis demonstrating that the Annex II tariff exemptions granted under the 2025 reciprocal tariff system generate between $218-$247 million in direct cost savings for the dietary supplement industry over a span of 69 days. The study highlights the critical role these exemptions play ...
Trade Associations Respond to Section 232 Investigation
In April, the U.S. Department of Commerce began an investigation under Section 232 of the Trade Expansion Act of 1962 to determine the effects on the national security of imports of pharmaceuticals, pharmaceutical ingredients and derivative products. After the investigation is complete, President Donald Trump will decide what action to take which could include tariffs. ...
Natural Products Industry Responds to Trump Tariffs
On April 2, President Donald Trump declared that “foreign trade and economic practices have created a national emergency.” His executive order imposes responsive tariffs to “strengthen the international economic position of the United States and protect American workers.” Under the order, Trump imposed a 10 percent tariff on all countries effective April 5. There will ...
White House Announces Tariff Exemptions for Key Dietary Supplement Ingredients
The Trump administration has announced that certain dietary supplement and dietary ingredients have been excluded from the Harmonized Tariff Schedule (HTS) announcement on April 2. In the executive order, President Trump provided a list of goods and materials (Annex II) that are classified in the 8-digit subheadings of the HTS that are exempt. Some of ...
Industry Responds to Dr. Marty Makary’s Nomination as FDA Commissioner
On Nov. 22, President-elect Donald Trump nominated Dr. Marty Makary as commissioner for the U.S. Food and Drug Administration (FDA). He would succeed outgoing FDA Commissioner Robert Califf. Makary is a surgical oncologist at Johns Hopkins Hospital in Baltimore, MD. He is also a professor at the Johns Hopkins School of Medicine, a researcher, an ...
Industry Responds to RFK Jr.’s Nomination as HHS Director
On Nov. 14, President-elect Donald Trump nominated environmental attorney Robert F. Kennedy Jr. (RFK) as director of the Department of Health and Human Services (HHS). After ending his own presidential campaign, Kennedy endorsed Trump and has since launched “Make America Healthy Again,” a campaign that “prioritizes regenerative agriculture, protects natural resources and removes harmful toxins ...
President Trump Nominates Stephen Hahn as FDA Commissioner
According to Politico, President Donald Trump announced last week that he will nominate Stephen Hahn, MD, FASTRO, a cancer specialist and hospital administrator, to lead the FDA (U.S. Food and Drug Administration). Trump had been rumored to make this selection for several months. If confirmed by the Senate, the top FDA post would mark Hahn’s first ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listing:
Subscribe To Our Newsletter
Stay Informed! Breaking news, industry trends featured topics, and more.
Subscribe to our newsletter today!